Mounjaro Quick Pen Instructions: How to Use Yours Correctly

The biggest misconception: you do not need to attach a needle or dial anything

Most people who have ever given themselves an injection before (or have watched someone else do it) expect a preparation sequence: needle cap, dose setting, air bubble. The Mounjaro Quick Pen works differently. It is supplied factory-loaded with your prescribed dose and contains a built-in needle that is hidden before, during and after injection. You never see the needle, and there is nothing to dial.

What you actually do is this. Take the pen from the fridge a few minutes ahead of time so it is not ice cold. Check the viewing window, the liquid inside should be clear or slightly yellow with no floating particles. Remove the grey base cap by pulling it straight off (do not twist). Choose your injection site. Press the pen flat against your skin, then push the purple button. Hold it in place for ten seconds while you hear two clicks, the first when the injection starts, the second when it ends. Lift the pen away. The needle retracts on its own. That is the full sequence. Detailed step-by-step pictures appear in your leaflet, and the full injection walkthrough on this site covers each stage with additional context if you want it alongside the official guide.

One practical note: the Quick Pen is a single-use device. After injection, place it immediately in a dedicated sharps container, ordinary household bins are not appropriate for used pens, and your local pharmacy or GP surgery can advise on collection points.

The skin pinch question, and choosing your site each week

A question our prescribers hear regularly: do you need to pinch the skin first? For the Quick Pen at most sites, no, the device is designed for a flat-against-the-skin press. The exception some people find helpful is the upper arm, particularly if arm tissue is lean; check your Patient Information Leaflet or ask your prescriber if you are unsure for your specific situation.

Rotating sites each week matters more than people realise. Injecting repeatedly into the same small area of the abdomen, for example, can cause the tissue to thicken over time, which reduces how reliably the medicine is absorbed. The three approved sites are the abdomen (avoiding a two-inch circle around the navel), the front and outer thigh, and the upper arm. A simple system is to move around a mental clock face within each site before switching to the next body area.

Avoid skin that is bruised, tender, red, hard or affected by any skin condition. You can inject through light clothing in a pinch, though most people prefer direct skin contact for confidence that the pen is properly positioned. For more on injection technique in general, including what to do if you notice a bruise or lump at the site, there is further reading available.

Storage, temperature and what to check before you inject

Mounjaro Quick Pens are refrigerated medicines. They should be kept at 2–8°C, typically the middle shelf of a household fridge, away from the freezer compartment and away from the door (where temperatures fluctuate most). Your Mounjaro storage guide covers the rules in full, including what to do if the pen has accidentally frozen or been left out.

If you need to travel or store the pen outside a fridge temporarily, the Patient Information Leaflet specifies an exact room-temperature window. Follow that figure precisely, do not guess based on general medicine advice. Once that window passes, the pen should not be used, even if the liquid looks unchanged.

Before every injection, inspect the liquid through the viewing window. Clear to faintly yellow is normal. Cloudy, discoloured or visibly particulate liquid means the pen should not be used; contact your prescriber or pharmacist. The price you pay for treatment, whether through the NHS or privately, is not a reason to use a pen that fails this check, your clinical team would rather you flag it than proceed with a compromised device. For context on what private tirzepatide treatment costs and what affects pricing, this overview of Eli Lilly's UK price changes is worth a read.

After the injection: what is normal, and when to seek help

A small amount of blood or clear fluid at the injection site is normal and does not mean the dose was lost. You can press gently with a clean finger for a few seconds; do not rub. Mild redness or a small raised area at the site usually settles within a day or two.

The most common side effects with tirzepatide are gastrointestinal, nausea, loose stools, constipation and indigestion feature most often, particularly in the days following a dose increase. Eating smaller portions, staying well hydrated and avoiding very fatty foods can help. These effects tend to be at their most noticeable at the start of treatment and after each step up in dose, then ease as your body adjusts. NHS guidance on tirzepatide covers the full side-effect profile in plain language.

Seek urgent medical attention if you develop severe, persistent abdominal pain that spreads to your back, with or without vomiting. This may be a sign of acute pancreatitis, which the MHRA highlighted as a known (though infrequent) concern in its January 2026 Drug Safety Update for GLP-1 medicines. Other signs that need same-day assessment include symptoms of a serious allergic reaction (facial swelling, difficulty breathing) or severe dehydration from prolonged vomiting or diarrhoea. Suspected side effects can be reported directly to the MHRA at Yellow Card.

If this is your first time using Mounjaro or you are moving from another device to the Quick Pen format, a review of the KwikPen instructions can help you understand how the two devices differ, the process, needle handling and dose windows are not identical.